Fig. 9From: The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysisForest plots of the subgroup analysis on the effects of antiangiogenic drugs on ORR. VEGF: vascular endothelial growth factor, VEGFR: vascular endothelial growth factor receptorBack to article page